STOCK TITAN

InMode to Present at March Investor Conferences and Events

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
InMode Ltd. (INMD) announces participation in key investor conferences in March 2024, showcasing top executives and presenting innovative medical technologies.
Positive
  • None.
Negative
  • None.

YOKNEAM, Israel, March 4, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in March:

INMODE Logo

Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Presenters: Moshe Mizrahy, Chief Executive Officer and Chairman

Format: Virtual fireside chat moderated by Suraj Kalia, Managing Director, Med Device Research Analyst, and one-on-one meetings

When: Tuesday, March 12 at 8:00 am ET

A live webcast of the presentation can be accessed here.

2024 Barclays Global Healthcare Conference

Presenters: Yair Malca, Chief Financial Officer, and Dr. Spero Theodorou, Chief Medical Officer

Format: In-person fireside chat moderated by Matt Miksic, Senior Equity Analyst, and one-on-one meetings

Where: Miami, FL

When: Wednesday, March 13 at 3:05 pm ET

A live webcast of the presentation can be accessed here.

Jefferies Miami MedTech Doctor Summit

Presenters: Dr. Spero Theodorou, Chief Medical Officer

Format: Aesthetics/Plastic Surgery Panel

Where: Miami, FL

When: Friday, March 15 at 11:00 am ET

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia

MS-IR LLC

ir@inmodemd.com 

917-607-8654 

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-march-investor-conferences-and-events-302074713.html

SOURCE InMode LTD

FAQ

When is InMode Ltd. participating in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference?

InMode Ltd. will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on Tuesday, March 12 at 8:00 am ET.

Who are the presenters from InMode Ltd. at the 2024 Barclays Global Healthcare Conference?

The presenters from InMode Ltd. at the 2024 Barclays Global Healthcare Conference are Yair Malca, Chief Financial Officer, and Dr. Spero Theodorou, Chief Medical Officer.

What format will the presentation at the Jefferies Miami MedTech Doctor Summit by InMode Ltd. follow?

The presentation at the Jefferies Miami MedTech Doctor Summit by InMode Ltd. will follow an Aesthetics/Plastic Surgery Panel format.

InMode Ltd. Ordinary Shares

NASDAQ:INMD

INMD Rankings

INMD Latest News

INMD Stock Data

1.55B
75.70M
9.69%
65.69%
6.98%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
Yokne'am

About INMD

inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and contraction. lumecca: broad spectrum pulsed light for rejuvenation of photo-damaged skin in a wide variety of skin types. diolaze: ultra fast diode hair removal featuring simultaneous 3pc (pre, parallel, and post cooling) technology and state of the art pulsing and power. bodyfx: non-invasive body contouring for buttocks, abdomen, flanks and thighs with a.c.e. technology